RedHill Biopharma (RDHL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
RedHill Biopharma Ltd. recently held its Annual General Meeting, with shareholders approving all proposed resolutions. Key decisions include the appointment of Kesselman & Kesselman as auditors for 2024, the re-election of two board members alongside a new member, and the approval of restricted share units for non-executive directors, the CEO, and the Chief Commercial Officer.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.